These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 3135739

  • 21. Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia.
    Hammill SC, McLaran CJ, Wood DL, Osborn MJ, Gersh BJ, Holmes DR.
    J Am Coll Cardiol; 1987 Jun; 9(6):1364-8. PubMed ID: 3584724
    [Abstract] [Full Text] [Related]

  • 22. [Effects of intravenous flecainide acetate in patients with concealed atrioventricular pathway with supraventricular tachycardia].
    Song Y.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):361-3, 397. PubMed ID: 1821351
    [Abstract] [Full Text] [Related]

  • 23. [Electrophysiologic effects of intravenous flecainide in intranodal junctional tachycardia in 30 patients].
    Haissaguerre M, Warin JF, Goldrach S, Le Métayer P, Guillem JP, Blanchot P.
    Arch Mal Coeur Vaiss; 1988 Dec; 81(12):1493-8. PubMed ID: 3147639
    [Abstract] [Full Text] [Related]

  • 24. Concealed anterograde accessory pathway conduction during the induction of orthodromic reciprocating tachycardia.
    Kou WH, Morady F, Dick M, Nelson SD, Baerman JM.
    J Am Coll Cardiol; 1989 Feb; 13(2):391-8. PubMed ID: 2913117
    [Abstract] [Full Text] [Related]

  • 25. [Wolff-Parkinson-White syndrome with orthodromic supraventricular tachycardia associated with a "hyper-conductor" atrio-ventricular node. A therapeutic challenge].
    Hernández González D, Iturralde Torres P, Romero L, Colín L, Villarreal A, González Hermosillo JA.
    Arch Inst Cardiol Mex; 1990 Feb; 60(2):175-81. PubMed ID: 2378538
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Electrophysiologic effect of a new Ca(2+)-antagonist, TA-3090 on supraventricular tachycardia and conduction system].
    Tanno K, Kobayashi Y, Miyata A, Chiyoda K, Nakagawa H, Kurano K, Kikushima S, Yazawa T, Baba T, Mukai H.
    Kokyu To Junkan; 1992 Sep; 40(9):897-902. PubMed ID: 1439290
    [Abstract] [Full Text] [Related]

  • 33. [His bundle block 2:1 during paroxysmal supraventricular tachycardia involving an occult accessory atrio-His pathway].
    Finzi A, Potenza S, Guenzati G.
    G Ital Cardiol; 1990 Dec; 20(12):1161-7. PubMed ID: 2128068
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of intravenous sotalol for suppressing inducibility of supraventricular tachycardias at rest and during isometric exercise.
    Huikuri HV, Koistinen MJ, Takkunen JT.
    Am J Cardiol; 1992 Feb 15; 69(5):498-502. PubMed ID: 1736614
    [Abstract] [Full Text] [Related]

  • 35. Tachycardia cycle length and maximum capacity of anterograde and retrograde atrioventricular conduction in paroxysmal supraventricular tachycardia.
    Sadr-Ameli MA, Lacombe P, Fromer M, Nadeau R, Shenasa M.
    Can J Cardiol; 1988 Apr 15; 4(3):134-9. PubMed ID: 3378196
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Clinical and electrophysiologic effects of magnesium sulfate on paroxysmal supraventricular tachycardia and comparison with adenosine triphosphate.
    Viskin S, Belhassen B, Sheps D, Laniado S.
    Am J Cardiol; 1992 Oct 01; 70(9):879-85. PubMed ID: 1529941
    [Abstract] [Full Text] [Related]

  • 38. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
    Fauchier JP, Cosnay P, Rouesnel P, Moquet B, Bonnet P, Scala PJ, Demeyer JF.
    Arch Mal Coeur Vaiss; 1985 Oct 01; 78 Spec No():81-90. PubMed ID: 3938264
    [Abstract] [Full Text] [Related]

  • 39. Use of intracardiac recordings to determine the site of drug action in paroxysmal supraventricular tachycardia.
    Jackman WM, Friday KJ, Fitzgerald DM, Yeung-Lai-Wah JA, Lazzara R.
    Am J Cardiol; 1988 Dec 20; 62(19):8L-19L. PubMed ID: 3059792
    [Abstract] [Full Text] [Related]

  • 40. Electrophysiologic effects, clinical efficacy and safety of intravenous and oral nadolol in refractory supraventricular tachyarrhythmias.
    Saksena S, Klein GJ, Kowey PR, Calvo RA, Boccadamo R, Brown JE, Sharma AD, Gadhoke A, Olukotun AY.
    Am J Cardiol; 1987 Feb 01; 59(4):307-12. PubMed ID: 3812280
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.